NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
For these individuals, alternative treatment options, including Radiofrequency (RF) ablation therapy, offer a promising solution. NeuroOne’s OneRF ® ablation system, is the first and only FDA 510 ...
The Manila Times2d
AirHelp Secures Significant Minority Investment from Abry Partners
AirHelp Inc. ('AirHelp'), the global leader in air passenger rights and compensation claims management, is excited to announce a significant minority investment from Abry Partners ('Abry'), a leading ...
The Manila Times3d
Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with Acumen Pharmaceuticals (NASDAQ: ABOS) CEO Daniel O ' Connell and Jessica Clark, ...
NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy
Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: ...
MassDevice10d
NeuroOne accelerates FDA submission timeline for nerve ablation tech
NeuroOne announced today that it accelerated the anticipated timeline of the FDA submission for its nerve ablation tech.
NeuroOne accelerates timeline of submission for OneRF trigeminal nerve ablation
Technologies accelerated the anticipated timeline of its 510(k) submission to the FDA for trigeminal nerve ablation to ...
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies ...
Nasdaq16d
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving ...
KKEY16d
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving ...
Mena FN16d
Neuroone® To Present At The Oppenheimer 35Th Annual Healthcare Medtech & Services Conference
(MENAFN- GlobeNewsWire - Nasdaq) EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the ...
ETF Daily News17d
Head to Head Comparison: Titan Medical (NASDAQ:TMDIF) and NeuroOne Medical Technologies (NASDAQ:NMTC)
Titan Medical has higher revenue and earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it ...
Wall Street Journal21d
NeuroOne Medical Technologies Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...